Using the gene scissors CRISPR and stem cells, researchers at Stockholm University and the UK Dementia Research Institute (UK ...

In honor of ALS Awareness Month, I AM ALS is rallying the nation on Thursday, May 22 for a Day of Action to shine a light on ...

The FDA in the US has granted clearance to BrainStorm to commence a Phase IIIb trial of its NurOwn therapy for ALS.

Peptidomimetics are synthetic analogs that retain the essential structure and function of peptides but with chemical ...

MaaT033, an experimental oral therapy that uses bacteria to restore balance in the gut, may slow ALS progression, a study ...

Understand how CT metrics match FVC in predicting ALS survival, offering a spirometry alternative for patients with bulbar ...

Unlike other pathologies, amyotrophic lateral sclerosis (ALS) cannot be reproduced accurately in animal models, complicating ...

Low-dose interleukin-2 as an add-on therapy to riluzole (Rilutek) led to a non-significant reduction in mortality in an ...

Health and Human Services Secretary Robert F. Kennedy Jr. defended his proposed budget for next year on Tuesday amid ...

MaaT Pharma Announces Promising Final Data Readout for Phase 1b Evaluating MaaT033 in Amyotrophic Lateral Sclerosis (ALS) ...